These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34290222)

  • 1. Contributing factors to advanced brain aging in depression and anxiety disorders.
    Han LKM; Schnack HG; Brouwer RM; Veltman DJ; van der Wee NJA; van Tol MJ; Aghajani M; Penninx BWJH
    Transl Psychiatry; 2021 Jul; 11(1):402. PubMed ID: 34290222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain aging in major depressive disorder: results from the ENIGMA major depressive disorder working group.
    Han LKM; Dinga R; Hahn T; Ching CRK; Eyler LT; Aftanas L; Aghajani M; Aleman A; Baune BT; Berger K; Brak I; Filho GB; Carballedo A; Connolly CG; Couvy-Duchesne B; Cullen KR; Dannlowski U; Davey CG; Dima D; Duran FLS; Enneking V; Filimonova E; Frenzel S; Frodl T; Fu CHY; Godlewska BR; Gotlib IH; Grabe HJ; Groenewold NA; Grotegerd D; Gruber O; Hall GB; Harrison BJ; Hatton SN; Hermesdorf M; Hickie IB; Ho TC; Hosten N; Jansen A; Kähler C; Kircher T; Klimes-Dougan B; Krämer B; Krug A; Lagopoulos J; Leenings R; MacMaster FP; MacQueen G; McIntosh A; McLellan Q; McMahon KL; Medland SE; Mueller BA; Mwangi B; Osipov E; Portella MJ; Pozzi E; Reneman L; Repple J; Rosa PGP; Sacchet MD; Sämann PG; Schnell K; Schrantee A; Simulionyte E; Soares JC; Sommer J; Stein DJ; Steinsträter O; Strike LT; Thomopoulos SI; van Tol MJ; Veer IM; Vermeiren RRJM; Walter H; van der Wee NJA; van der Werff SJA; Whalley H; Winter NR; Wittfeld K; Wright MJ; Wu MJ; Völzke H; Yang TT; Zannias V; de Zubicaray GI; Zunta-Soares GB; Abé C; Alda M; Andreassen OA; Bøen E; Bonnin CM; Canales-Rodriguez EJ; Cannon D; Caseras X; Chaim-Avancini TM; Elvsåshagen T; Favre P; Foley SF; Fullerton JM; Goikolea JM; Haarman BCM; Hajek T; Henry C; Houenou J; Howells FM; Ingvar M; Kuplicki R; Lafer B; Landén M; Machado-Vieira R; Malt UF; McDonald C; Mitchell PB; Nabulsi L; Otaduy MCG; Overs BJ; Polosan M; Pomarol-Clotet E; Radua J; Rive MM; Roberts G; Ruhe HG; Salvador R; Sarró S; Satterthwaite TD; Savitz J; Schene AH; Schofield PR; Serpa MH; Sim K; Soeiro-de-Souza MG; Sutherland AN; Temmingh HS; Timmons GM; Uhlmann A; Vieta E; Wolf DH; Zanetti MV; Jahanshad N; Thompson PM; Veltman DJ; Penninx BWJH; Marquand AF; Cole JH; Schmaal L
    Mol Psychiatry; 2021 Sep; 26(9):5124-5139. PubMed ID: 32424236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerated functional brain aging in major depressive disorder: evidence from a large scale fMRI analysis of Chinese participants.
    Luo Y; Chen W; Qiu J; Jia T
    Transl Psychiatry; 2022 Sep; 12(1):397. PubMed ID: 36130921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between age and the course of major depressive disorder: a 2-year longitudinal cohort study.
    Schaakxs R; Comijs HC; Lamers F; Kok RM; Beekman ATF; Penninx BWJH
    Lancet Psychiatry; 2018 Jul; 5(7):581-590. PubMed ID: 29887519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative stress in major depressive and anxiety disorders, and the association with antidepressant use; results from a large adult cohort.
    Black CN; Bot M; Scheffer PG; Penninx BW
    Psychol Med; 2017 Apr; 47(5):936-948. PubMed ID: 27928978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The network structure of major depressive disorder, generalized anxiety disorder and somatic symptomatology.
    Bekhuis E; Schoevers RA; van Borkulo CD; Rosmalen JG; Boschloo L
    Psychol Med; 2016 Oct; 46(14):2989-2998. PubMed ID: 27523095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional brain volume in depression and anxiety disorders.
    van Tol MJ; van der Wee NJ; van den Heuvel OA; Nielen MM; Demenescu LR; Aleman A; Renken R; van Buchem MA; Zitman FG; Veltman DJ
    Arch Gen Psychiatry; 2010 Oct; 67(10):1002-11. PubMed ID: 20921116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma insulin-like growth factor I levels are higher in depressive and anxiety disorders, but lower in antidepressant medication users.
    Bot M; Milaneschi Y; Penninx BW; Drent ML
    Psychoneuroendocrinology; 2016 Jun; 68():148-55. PubMed ID: 26974499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of ADHD symptoms across clinical stages of major depressive disorder.
    Bron TI; Bijlenga D; Verduijn J; Penninx BW; Beekman AT; Kooij JJ
    J Affect Disord; 2016 Jun; 197():29-35. PubMed ID: 26970265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uric acid in major depressive and anxiety disorders.
    Black CN; Bot M; Scheffer PG; Snieder H; Penninx BWJH
    J Affect Disord; 2018 Jan; 225():684-690. PubMed ID: 28917195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of depression and anxiety treatment on biological aging and metabolic stress: study protocol of the MOod treatment with antidepressants or running (MOTAR) study.
    Lever-van Milligen BA; Verhoeven JE; Schmaal L; van Velzen LS; Révész D; Black CN; Han LKM; Horsfall M; Batelaan NM; van Balkom AJLM; van Schaik DJF; van Oppen P; Penninx BWJH
    BMC Psychiatry; 2019 Dec; 19(1):425. PubMed ID: 31888565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma Testosterone and the Course of Major Depressive Disorder in Older Men and Women.
    Giltay EJ; van der Mast RC; Lauwen E; Heijboer AC; de Waal MWM; Comijs HC
    Am J Geriatr Psychiatry; 2017 Apr; 25(4):425-437. PubMed ID: 28132748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic Aging in Major Depressive Disorder.
    Han LKM; Aghajani M; Clark SL; Chan RF; Hattab MW; Shabalin AA; Zhao M; Kumar G; Xie LY; Jansen R; Milaneschi Y; Dean B; Aberg KA; van den Oord EJCG; Penninx BWJH
    Am J Psychiatry; 2018 Aug; 175(8):774-782. PubMed ID: 29656664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omega-3 and omega-6 fatty acid levels in depressive and anxiety disorders.
    Thesing CS; Bot M; Milaneschi Y; Giltay EJ; Penninx BWJH
    Psychoneuroendocrinology; 2018 Jan; 87():53-62. PubMed ID: 29040890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major depressive disorder, antidepressant use, and subsequent 2-year weight change patterns in the Netherlands Study of Depression and Anxiety.
    Gibson-Smith D; Bot M; Milaneschi Y; Twisk JW; Visser M; Brouwer IA; Penninx BW
    J Clin Psychiatry; 2016 Feb; 77(2):e144-51. PubMed ID: 26760137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accelerated brain aging in major depressive disorder and antidepressant treatment response: A CAN-BIND report.
    Ballester PL; Suh JS; Nogovitsyn N; Hassel S; Strother SC; Arnott SR; Minuzzi L; Sassi RB; Lam RW; Milev R; Müller DJ; Taylor VH; Kennedy SH; Frey BN;
    Neuroimage Clin; 2021; 32():102864. PubMed ID: 34710675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of depressive symptom profiles between current major depressive disorder and schizophrenia spectrum disorder.
    Lange SMM; Schirmbeck F; Stek ML; Murk Jansen YR; van Rooijen G; de Haan L; Penninx BWJH; Rhebergen D;
    J Psychiatr Res; 2021 Mar; 135():143-151. PubMed ID: 33486162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolomic profiles discriminating anxiety from depression.
    de Kluiver H; Jansen R; Milaneschi Y; Bot M; Giltay EJ; Schoevers R; Penninx BWJH
    Acta Psychiatr Scand; 2021 Aug; 144(2):178-193. PubMed ID: 33914921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerated brain aging predicts impulsivity and symptom severity in depression.
    Dunlop K; Victoria LW; Downar J; Gunning FM; Liston C
    Neuropsychopharmacology; 2021 Apr; 46(5):911-919. PubMed ID: 33495545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Childhood trauma and its impact on depressive and anxiety symptomatology in adulthood: A 6-year longitudinal study.
    Kuzminskaite E; Vinkers CH; Milaneschi Y; Giltay EJ; Penninx BWJH
    J Affect Disord; 2022 Sep; 312():322-330. PubMed ID: 35760192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.